Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic immune thrombocytopenia
Pharma
Argenx builds clinical case for 'pipeline in a product' efgart
As efgartigimod gains traction in myasthenia gravis, argenx is out to prove its antibody fragment is no one-hit wonder.
Fraiser Kansteiner
Dec 10, 2022 11:30am
Grifols opens plant, snags NICE nod for Tavlesse
Oct 19, 2022 10:15am
Tiny Dova and its Doptelet drug take on Novartis blockbuster
Jun 28, 2019 10:25am
Dova wins FDA nod for platelet booster that could hit $600M
May 22, 2018 11:56am
Rigel snags first FDA win with Tavalisse OK
Apr 18, 2018 9:52am
